Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 May;147(5):e2021050212.
doi: 10.1542/peds.2021-050212.

Remdesivir: Preliminary Data and Clinical Use Versus Recommended Use

Affiliations
Comment

Remdesivir: Preliminary Data and Clinical Use Versus Recommended Use

Angelique E Boutzoukas et al. Pediatrics. 2021 May.
No abstract available

PubMed Disclaimer

Conflict of interest statement

POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conflicts of interest to disclose.

Comment on

  • Compassionate Use of Remdesivir in Children With Severe COVID-19.
    Goldman DL, Aldrich ML, Hagmann SHF, Bamford A, Camacho-Gonzalez A, Lapadula G, Lee P, Bonfanti P, Carter CC, Zhao Y, Telep L, Pikora C, Naik S, Marshall N, Katsarolis I, Das M, DeZure A, Desai P, Cao H, Chokkalingam AP, Osinusi A, Brainard DM, Méndez-Echevarría A. Goldman DL, et al. Pediatrics. 2021 May;147(5):e2020047803. doi: 10.1542/peds.2020-047803. Pediatrics. 2021. PMID: 33883243

References

    1. Pardo J, Shukla AM, Chamarthi G, Gupte A. The journey of remdesivir: from Ebola to COVID-19. Drugs Context. 2020;9 - PMC - PubMed
    1. Wang M, Cao R, Zhang L, et al. . Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30(3):269–271 - PMC - PubMed
    1. Beigel JH, Tomashek KM, Dodd LE, et al. .; ACTT-1 Study Group Members . Remdesivir for the treatment of Covid-19 - final report. N Engl J Med. 2020;383(19):1813–1826 - PMC - PubMed
    1. Food and Drug Administration. Approves first treatment for COVID-19. 2020. Available at: https://www.fda.gov/news-events/press-announcements/fda-approves-first-t.... Accessed October 22, 2020
    1. Goldman DL, Aldrich ML, Hagmann SHF, et al. . Compassionate use of remdesivir in children with severe COVID-19. Pediatrics. 2021;147(5):e2020047803 - PubMed

Publication types

MeSH terms

LinkOut - more resources